Freenome, Inc. (FRNM) stock
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.73−0.09 (-0.92%)
Close on Nov 18, 2026Market cap $1.08BP/E –Yield –
Freenome operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Freenome's operating income for the twelve months ending Sep 30, 2026 was $250.71M. For fiscal 2025 it was -$2.98M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.98M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $69.97M | – |
| Q2 FY2026 | Jun 30, 2026 | -$941.33K | – |
| Q1 FY2026 | Mar 31, 2026 | -$858.83K | – |
| Q4 FY2025 | Dec 31, 2025 | $182.54M | – |
| Q3 FY2025 | Sep 30, 2025 | -$65.26M | – |
| Q2 FY2025 | Jun 30, 2025 | -$193.20K | – |
| Q1 FY2025 | Mar 31, 2025 | -$255.96K | – |
| Q3 FY2024 | Sep 30, 2024 | -$196.13K | – |
| Q2 FY2024 | Jun 30, 2024 | -$121.95K | – |
See a number that looks wrong?